Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX: A2MThe a2 Milk Company LimitedConsumer Staples

a2 Milk Sees FY27 Earnings Weighted to Second Half

a2 Milk expects FY27 revenue growth of mid single digit percent and an Underlying EBITDA margin of about 15%, with earnings materially weighted to 2H27.

By Digifin Pty Ltd · About this coverage

Key Points

  • Estimated China label offtake at ~50% of pre-supply chain disruption levels, up from ~40% in August
  • FY27 revenue growth of mid single digit percent expected, with 1H27 slightly down on 1H26
  • Underlying EBITDA margin expected to be approximately 15%, with 1H27 materially down
  • Total IMF sales expected to be broadly similar to FY26
  • One-off transformation costs now expected to be ~$15 million in FY27
The a2 Milk Company Limited (ASX:A2M)

About a2 Milk (ASX:A2M)

The a2 Milk Company Limited is a dairy nutrition company headquartered in Auckland, with its securities quoted on the ASX under the code A2M and on the NZX. It markets infant milk formula, liquid milk and other nutritional products made from milk containing only the A2 beta-casein protein type. Its main markets are China and other parts of Asia, Australia and New Zealand, and the United States.

The a2 Milk (ASX:A2M) Company updated its FY27 outlook and China infant milk formula recovery at its Annual Meeting, with Group revenue and EBITDA now expected to be materially weighted to 2H27.

The company says shortfalls of China label IMF product in 4Q26 forced a large proportion of existing users to switch to alternative brands, with flow-on effects expected in FY27. Estimated China label offtake has recovered to ~50% of pre-supply chain disruption levels, up from ~40% in August 2026. Total IMF sales are expected to be broadly similar to FY26, with China label and English label expected to recover gradually over FY27, supported by two new China label products, the updated a2 Platinum product and increased marketing, particularly in 1H27. Against FY26, on a continuing operations basis, the company expects revenue growth of mid single digit percent, with 1H27 revenue slightly down on 1H26, and an Underlying EBITDA margin of approximately 15%, with 1H27 materially down on 1H26. It also expects capital expenditure of approximately $70 million. The company says the a2 Platinum transition to a2 Pōkeno is on track, with one-off transformation costs now expected to be ~$15 million in FY27 and none in FY28.

The company says a range of outcomes is possible depending on the rate of IMF recovery. The China importation requirements affecting a2 Genesis remain unresolved, and the release does not quantify the effect of the weaker NZD, saying the earnings uplift is offset by hedge losses.

Back to all ASX Company News

Source: The a2 Milk Company Limited (ASX:A2M), 19 November 2026. Summary content supplied by Digifin Pty Ltd.

News summary only, not financial advice. It does not consider your objectives, financial situation or needs.

Thursday, 19 November 2026

Also summarised today

All ASX Company News
ASX: AACConsumer Staples

AACo Half-Year Operating Profit Rises 63% to $64.8M

AACo lifted half-year Operating Profit 63% to $64.8 million on stronger beef prices, while statutory NPAT fell to $60.8 million on a lower herd value gain.

19 Nov, 8:14 am AEDT
ASX: C79Industrials

Chrysos Revenue Up 27% to $36.7m, FY27 Guidance Reaffirmed

Chrysos reported July to October revenue of $36.7m, up 27%, signed 15 new PhotonAssay leases in FY27 and reaffirmed FY27 revenue guidance of $108m to $118m.

19 Nov, 8:27 am AEDT
ASX: CGFFinancials

Challenger Says $12.20 TDA Revised Offer Not Fair Value

Challenger's Board says a revised non-binding $12.20 per share offer from TAL Daiichi Life Australia does not adequately represent fair value for shareholders.

19 Nov, 8:20 am AEDT
ASX: EHLIndustrials

Emeco Guides FY27 Operating EBITDA of $275M to $285M

Emeco expects FY27 Operating EBITDA of $275 million to $285 million, weighted 45/55 to the second half, with surface utilisation at 83% and underground at 73%.

19 Nov, 8:25 am AEDT
ASX: NUFMaterials

Nufarm FY26 Underlying EBITDA Rises 25% as Leverage Falls

Nufarm lifted FY26 underlying EBITDA 25% to $378.3 million and cut leverage to 2.0x, but reported a statutory net loss of $79.5 million after material items.

19 Nov, 8:25 am AEDT
ASX: OCAHealth Care

Oceania Healthcare Lifts Underlying EBITDA 18% in 1H27

Oceania Healthcare lifted 1H27 Underlying EBITDA 18% to NZ$49.0m and reported positive Cash Flow from Existing Operations, but declared no interim dividend.

19 Nov, 7:31 am AEDT
ASX: OMAEnergy

Omega Canyon North-1 Logs 191m Net Pay 25km North

Omega Oil & Gas says Canyon North-1 logged 191m of net pay across a 1,129m gross sequence 25km north of Canyon, though its petroleum reserves estimate is nil.

19 Nov, 8:35 am AEDT
ASX: SRLMaterials

Sunrise Energy Metals Gets FIRB Nod for US Redomicile

Sunrise Energy Metals has FIRB approval without conditions for its US redomicile, with a Scheme Meeting expected in January 2027 and Nasdaq trading in February.

19 Nov, 9:05 am AEDT
ASX: WTMMaterials

Waratah Minerals Secures A$50M Placement for Spur Drilling

Waratah Minerals has firm commitments for a A$50.0 million placement at A$0.65 per share to fund a +100,000 m drilling campaign at its Spur Gold Project.

19 Nov, 9:24 am AEDT

Announcement summaries are published each trading day. General advice only.

Copyright © 2026 SureStone Capital